Status:
COMPLETED
Radiomics-based Models for the Prediction of Pathological Response to Neoadjuvant Therapy in Gastric and Gastroesophageal Cancer
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Patients With Locally Advanced Carcinoma of the Stomach and Oesophagogastric Junction
Eligibility:
All Genders
Brief Summary
Identifying predictors of response to neoadjuvant therapy in gastric and gastro-oesophageal cancer early in the history of the disease would ensure optimal treatment planning. The study aims to apply...
Eligibility Criteria
Inclusion
- Patients with locally advanced stomach cancer undergoing neoadjuvant chemotherapy and gastrectomy between January 2005 and August 2022
Exclusion
- Siewert 1 tumors;
- Patients who have received neoadjuvant with the addition of a biological drug;
- Patients who have received radiotherapy;
- Patients without staging CT scan or with insufficient image quality in terms of phases performed, pixel spacing, slide thickness (mandatorily: \> 5 mm) or artefacts.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06044961
Start Date
January 1 2005
End Date
November 15 2022
Last Update
September 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.